|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/16 | |
| A61K 31/4985 | |||
| A61K 31/445 | |||
| A61P 25/00 |
| (11) | Number of the document | 3407888 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17744910.5 |
| Date of filing the European patent application | 2017-01-26 | |
| (97) | Date of publication of the European application | 2018-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/015178 |
| Date | 2017-01-26 |
| (87) | Number | WO 2017/132408 |
| Date | 2017-08-03 |
| (30) | Number | Date | Country code |
| 201662287264 P | 2016-01-26 | US | |
| 201662440130 P | 2016-12-29 | US |
| (72) |
YAO, Wei, US
LI, Peng, US
|
| (73) |
Intra-Cellular Therapies, Inc.,
430 East 29th Street, Suite 900, New York, NY 10016,
US
|
| (54) | PYRIDOPYRROLOQUINOXALINE COMPOUNDS, THEIR COMPOSITIONS AND USES |
| PYRIDOPYRROLOQUINOXALINE COMPOUNDS, THEIR COMPOSITIONS AND USES |